Vacancy on Board of Governors of the Patient-Centered Outcomes Research Institute (PCORI), 42794-42795 [2014-17238]

Download as PDF mstockstill on DSK4VPTVN1PROD with NOTICES 42794 Federal Register / Vol. 79, No. 141 / Wednesday, July 23, 2014 / Notices information, like medical records or other individually identifiable health information. In addition, do not include any ‘‘[t]rade secret or any commercial or financial information which . . . is privileged or confidential,’’ as discussed in Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2). In particular, do not include competitively sensitive information such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. If you want the Commission to give your comment confidential treatment, you must file it in paper form, with a request for confidential treatment, and you have to follow the procedure explained in FTC Rule 4.9(c), 16 CFR 4.9(c).1 Your comment will be kept confidential only if the FTC General Counsel, in his or her sole discretion, grants your request in accordance with the law and the public interest. Postal mail addressed to the Commission is subject to delay due to heightened security screening. As a result, we encourage you to submit your comments online. To make sure that the Commission considers your online comment, you must file it at https:// ftcpublic.commentworks.com/ftc/ plasticlumberconsent by following the instructions on the web-based form. If this Notice appears at https:// www.regulations.gov/#!home, you also may file a comment through that Web site. If you file your comment on paper, write ‘‘Engineered Plastic Systems, Consent Agreement; File No. 132 3204’’ on your comment and on the envelope, and mail your comment to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW., Suite CC– 5610 (Annex D), Washington, DC 20580, or deliver your comment to the following address: Federal Trade Commission, Office of the Secretary, Constitution Center, 400 7th Street SW., 5th Floor, Suite 5610 (Annex D), Washington, DC 20024. If possible, submit your paper comment to the Commission by courier or overnight service. Visit the Commission Web site at https://www.ftc.gov to read this Notice and the news release describing it. The FTC Act and other laws that the Commission administers permit the collection of public comments to 1 In particular, the written request for confidential treatment that accompanies the comment must include the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record. See FTC Rule 4.9(c), 16 CFR 4.9(c). VerDate Mar<15>2010 17:33 Jul 22, 2014 Jkt 232001 consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before August 18, 2014. You can find more information, including routine uses permitted by the Privacy Act, in the Commission’s privacy policy, at https://www.ftc.gov/ftc/privacy.htm. Analysis of Proposed Consent Order To Aid Public Comment The Federal Trade Commission (‘‘FTC’’ or ‘‘Commission’’) has accepted, subject to final approval, an agreement containing a consent order from Engineered Plastic Systems, LLC, a limited liability company (‘‘Respondent’’). The proposed consent order has been placed on the public record for thirty (30) days for receipt of comments by interested persons. Comments received during this period will become part of the public record. After thirty (30) days, the Commission will again review the agreement and the comments received, and will decide whether it should withdraw from the agreement or make final the agreement’s proposed order. This matter addresses allegedly deceptive green claims that Respondent made while promoting its plastic lumber products. According to the FTC complaint, Respondent represented that some of its benches and tables are all, or virtually all, recycled plastic. The complaint also alleges that these products contained substantially less recycled plastic than Respondent represented. According to the complaint, from June 2011 to early 2014, Respondent’s tables and benches, on average, contained only about 72% recycled plastic. Thus, the complaint alleges that the above claims were false, misleading, or unsubstantiated in violation of Section 5(a) of the FTC Act. The proposed consent order contains several provisions designed to prevent Respondent from engaging in similar acts and practices in the future. Part I prohibits Respondent from making representations regarding the recycled content or the environmental benefit of any product or package unless they are true, not misleading, and substantiated by competent and reliable evidence. Part I further provides that if, in general, experts in the relevant scientific field would conclude it necessary, such evidence must be competent and reliable scientific evidence. Consistent with the Guides for the Use of Environmental Marketing Claims (‘‘Green Guides’’), 16 CFR 260.13(b), Part I specifically requires Respondent to substantiate recycled content claims by demonstrating that such content is PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 composed of materials that were recovered or otherwise diverted from the waste stream. Parts II through VI are reporting and compliance provisions. Part II requires Respondent to keep (and make available to the Commission on request): copies of advertisements and promotional materials containing the representations covered by the order; materials relied upon in disseminating those representations; and evidence that contradicts, qualifies, or calls into question the representations, or the basis relied upon for the representations. Part III requires dissemination of the order now and in the future to principals, officers, directors, and managers, and to all current and future employees, agents, and representatives having responsibilities relating to the subject matter of the order. It also requires Respondent to maintain and make available to the FTC all acknowledgments of receipt of the order. Part IV requires notification to the FTC of changes in corporate status. Part V mandates that Respondent submit an initial compliance report to the FTC and subsequent reports requested by the FTC. Part VI is a provision terminating the order after twenty (20) years, with certain exceptions. The purpose of this analysis is to aid public comment on the proposed consent order. It is not intended to constitute an official interpretation of the proposed order or to modify its terms in any way. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2014–17285 Filed 7–22–14; 8:45 am] BILLING CODE 6750–01–P GOVERNMENT ACCOUNTABILITY OFFICE Vacancy on Board of Governors of the Patient-Centered Outcomes Research Institute (PCORI) Government Accountability Office (GAO). ACTION: Notice on letters of nomination. AGENCY: The Patient Protection and Affordable Care Act gave the Comptroller General of the United States responsibility for appointing 19 members to the Board of Governors the Patient-Centered Outcomes Research Institute and for filling vacancies that may occur. Board members must meet the qualifications listed in Section 6301 of the Act, including one member SUMMARY: E:\FR\FM\23JYN1.SGM 23JYN1 Federal Register / Vol. 79, No. 141 / Wednesday, July 23, 2014 / Notices representing quality improvement or independent health services researchers. Due to a vacancy on the board in this category, I am announcing the following: letters of nomination and resumes should be submitted by August 15, 2014 to ensure adequate opportunity for review and consideration of nominees prior to appointment. Letters of nomination and resumes can be sent to either the email or mailing address listed below. ADDRESSES: Nominations can be submitted by either of the following: Email: PCORI@gao.gov. Mail: U.S. GAO, Attn: PCORI Appointments, 441 G Street NW., Washington, DC 20548. FOR MORE INFORMATION CONTACT: GAO: Office of Public Affairs, (202) 512–4800. effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, NIOSH, 1090 Tusculum Avenue, MS C– 46, Cincinnati, OH 45226–1938, Telephone 1–877–222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2014–17320 Filed 7–22–14; 8:45 am] BILLING CODE 4163–19–P Authority: Sec. 6301, Pub. L. 111–148. DEPARTMENT OF HEALTH AND HUMAN SERVICES Gene L. Dodaro, Comptroller General of the United States. [FR Doc. 2014–17238 Filed 7–22–14; 8:45 am] Meeting of the Presidential Advisory Council on HIV/AIDS BILLING CODE 1610–02–M Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HHS gives notice of a decision to designate a class of employees from the Nuclear Metals, Inc. facility in West Concord, Massachusetts, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On July 11, 2014, the Secretary of HHS designated the following class of employees as an addition to the SEC: mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: ‘‘All Atomic Weapons Employees who worked at the facility owned by Nuclear Metals, Inc. (or a subsequent owner) in West Concord, Massachusetts, during the period from January 1, 1980, through December 31, 1990, for a number of work days aggregating at least 250 work days, occurring either solely under this employment, or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.’’ This designation will become effective on August 10, 2014, unless Congress provides otherwise prior to the VerDate Mar<15>2010 17:33 Jul 22, 2014 Jkt 232001 As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Service (DHHS) is hereby giving notice that the Presidential Advisory Council on HIV/AIDS (PACHA) will hold a meeting to discuss HIV/AIDS in the Southern United States, HIV related workforce issues, and Hepatitis C and the impact of the Affordable Care Act. The meeting will be open to the public. DATES: The meeting will be held on September 4, 2014, from 9:00 a.m. to approximately 5:00 p.m. (EDT) and September 5, 2014, from 9:00 a.m. to approximately 12:30 p.m. (EDT). ADDRESSES: The Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. On September 4, the meeting will be held in the auditorium of the Hubert H. Humphrey Building. On September 5, the meeting will be held in the Great Hall of the Hubert H. Humphrey Building. FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, Public Health Analyst, Presidential Advisory Council on HIV/ AIDS, U.S Department of Health and Human Services, 200 Independence Avenue SW., Room 443H, Washington, DC 20201; (202) 205–1178. More detailed information about PACHA can SUMMARY: PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 42795 be obtained by accessing the Council’s Web site www.aids.gov/pacha. SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 12963, dated June 14, 1995, as amended by Executive Order 13009, dated June 14, 1996. The Council was established to provide advice, information, and recommendations to the Secretary regarding programs and policies intended to promote effective prevention of HIV disease and AIDS. The functions of the Council are solely advisory in nature. The Council consists of not more than 25 members. Council members are selected from prominent community leaders with particular expertise in, or knowledge of, matters concerning HIV and AIDS, public health, global health, philanthropy, marketing or business, as well as other national leaders held in high esteem from other sectors of society. Council members are appointed by the Secretary or designee, in consultation with the White House Office on National AIDS Policy. The agenda for the upcoming meeting will be posted on the Council’s Web site at www.aids.gov/pacha. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Due to space constraints, pre-registration for public attendance is advisable and can be accomplished by contacting Caroline Talev at caroline.talev@hhs.gov by close of business Wednesday, August 20, 2014. Members of the public will have the opportunity to provide comments at the meeting. Any individual who wishes to participate in the public comment session must register with Caroline Talev at caroline.talev@hhs.gov by close of business Wednesday, August 20, 2014; registration for public comment will not be accepted by telephone. Individuals are encouraged to provide a written statement of any public comment(s) for accurate minute taking purposes. Public comment will be limited to two minutes per speaker. Any members of the public who wish to have printed material distributed to PACHA members at the meeting should submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no later than close of business August 20, 2014. Dated: July 9, 2014. B. Kaye Hayes, Executive Director, Presidential Advisory Council on HIV/AIDS. [FR Doc. 2014–17271 Filed 7–22–14; 8:45 am] BILLING CODE 4150–43–P E:\FR\FM\23JYN1.SGM 23JYN1

Agencies

Government Accountability Office

[Federal Register Volume 79, Number 141 (Wednesday, July 23, 2014)]
[Notices]
[Pages 42794-42795]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17238]


=======================================================================
-----------------------------------------------------------------------

GOVERNMENT ACCOUNTABILITY OFFICE


Vacancy on Board of Governors of the Patient-Centered Outcomes 
Research Institute (PCORI)

AGENCY: Government Accountability Office (GAO).

ACTION: Notice on letters of nomination.

-----------------------------------------------------------------------

SUMMARY: The Patient Protection and Affordable Care Act gave the 
Comptroller General of the United States responsibility for appointing 
19 members to the Board of Governors the Patient-Centered Outcomes 
Research Institute and for filling vacancies that may occur. Board 
members must meet the qualifications listed in Section 6301 of the Act, 
including one member

[[Page 42795]]

representing quality improvement or independent health services 
researchers. Due to a vacancy on the board in this category, I am 
announcing the following: letters of nomination and resumes should be 
submitted by August 15, 2014 to ensure adequate opportunity for review 
and consideration of nominees prior to appointment. Letters of 
nomination and resumes can be sent to either the email or mailing 
address listed below.

ADDRESSES: Nominations can be submitted by either of the following:
    Email: PCORI@gao.gov.
    Mail: U.S. GAO, Attn: PCORI Appointments, 441 G Street NW., 
Washington, DC 20548.

For More Information Contact:
    GAO: Office of Public Affairs, (202) 512-4800.

    Authority:  Sec. 6301, Pub. L. 111-148.

Gene L. Dodaro,
Comptroller General of the United States.
[FR Doc. 2014-17238 Filed 7-22-14; 8:45 am]
BILLING CODE 1610-02-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.